JUSTIN KEMP: Open Payments
NPI 1255688016 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,048 in 120 payments from 14 companies in 2025. Trend: 2023 $1,987 · 2024 $1,245 · 2025 $2,048
Food & beverage: $2,048
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $651 |
| ABBVIE INC. | 34 | $473 |
| PFIZER INC. | 21 | $220 |
| GlaxoSmithKline, LLC. | 16 | $210 |
| Otsuka America Pharmaceutical, Inc. | 13 | $188 |
| Lundbeck LLC | 5 | $90 |
| Amgen Inc. | 5 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Seqirus USA Inc | 1 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
Products named: AIRSUPRA, REXULTI, TRELEGY ELLIPTA, QULIPTA, UBRELVY, NURTEC ODT, VRAYLAR, BREZTRI.
Industry payments across AR — which companies pay providers there.
